Scientists discovered a new inflammatory marker known as IL-6 in middle-aged adults blood. The new biomarkers can detect the prior development of serious health complications such as cancer, heart disease etc. Scientists analyzed data collected between 1997 and 1999 of 6,545 individuals aged between 45 and 69 years. The discovery of the new biomarkers can lead to the development of new treatment methods for chronic diseases. Lead author of the study is Prof Archana Singh-Manoux, University College London and the study findings were published in the Canadian Medical Association Journal.
FDA cleared CONTOUR ® NEXT ONE blood glucose monitoring system, manufactured by Ascensia Diabetes Care. The product will be available in US market in early 2017. Features of CONTOUR ® NEXT ONE are
Siren Care, diabetes tracking company says the diabetic health of a patient can be tracked in a better and in an innovative way. The business idea of the Siren Care is to integrate textiles, sensors and user-friendly software to show actionable data to the user (patient) and healthcare professionals. Healthcare professionals take decisions on user's health based on the actionable data provided by the smart product.
Previous studies show type 1 and type 2 diabetes patients may experience foot swelling and infection. Studies show skin inflammation is associated with a rise in skin temperature and 72 percent of foot ulcers can be prevented by monitoring temperature. Foot ulcers are preventable and untreated foot problems may lead to foot surgery and amputation. According to the American Podiatric Medical Association, 14 to 24 percent of diabetic patients with foot ulcers may undergo amputation.
The company unveiled smart socks product that uses temperature to identify diabetes complication in foot such as ulcers in a patient. Users of Smart Care Smart Socks receives an alert message before the development of the foot ulcers. Foot ulcers are the common reason for a diabetes patient to stay at the hospital. The product uses wearable temperature sensors in smart socks to detect and track diabetes and they don't require charging. Each of this wearable socks lasts for 6 months. They are in "ON" mode whenever the user wears it and in "SLEEP" mode whenever he removes it. A smartphone App supports the smart socks. App sends an alert message (indicating foot needs examination by a medical professional) when sensors in smart socks detect temperature difference in the foot. A user can wash them without destroying smart sensing capabilities of the product.
Siren Care company is planning to integrate textiles, software Apps and sensors to monitor moisture, pressure, light, LEDs, RFIDs, MCU, BLE, etc to detect multiple health complications of individuals. Previously, Orpyx Medical Technologies developed a wireless shoe, SurroSense RX to detect and track peripheral neuropathy. Its technology was based on pressure exerted on each foot on insoles embedded sensors.
ITCA 650 is a product of Intarcia Therapeutics Inc in partnership with Servier pharmaceutical, France. The product is equipped with a matchstick-size implantable drug-delivery pump, which can be replaced once or twice in a year, to deliver exenatide diabetes medication to patients with type 2 diabetes (T2D). The company filed an application to the American Diabetes Association (ADA) for approval. After approval, this product could be first injection-free GLP-1 therapy. The company is planning to launch the product during mid-2017.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.